IRCT20200105046010N64招募中未知
In- Vivo Bioequivalence study of Dapoxetine tablet 30 mg Mofid Pharma (DAPROLONG® 30 mgTab, Mofid Pharma, Iran) with brand drugs (PRILIGY® 30 mg Tab, Menarini, Italy) in Iranian healthy volunteers.
Teb Mofid Nikan Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-60 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
Unknown
Bioequivalence study of dapoxetine 60 mg tablet---.IRCT20230222057495N8Sami Saz Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of Dapoxetine 60 mg Tablet (Pharma Chemie Pharmaceutical Company) versus Priligy ?? mg (ALZA corporation) Tablet in healthy volunteersIRCT20220111053692N12???? ???????? ????? ????24
招募中
Unknown
Bioequivalence evaluation of Dapoxetine 60 mg capsule of Actover Pharmaceutical companyIRCT20200625047913N16Hezareh Sevom Futuristic Pharmacist24
招募中
不适用
In-vivo Bioequivalence Test of Dasatonib tablet 100 mg Abidi Pharma with brand drug (SPRYCEL® 100 mg FC Tab, Bristol-Myers Squibb, UK)Bio equivalence test.IRCT20200105046010N66Abidi Pharmaceutical Company24
尚未招募
不适用
Bioequivalence of DuloxetineHealthy subjects.IRCT20210201050197N1?Arya Pharmaceutical Company26